Implementation of TERT promoter mutations improve prognostication of the WHO classification in meningioma.
Mirian C, Grell K, Juratli TA, Sahm F, Spiegl-Kreinecker S, Peyre M, Biczok A, Tonn JC, Goutagny S, Bertero L, Maier AD, Jensen LR, Schackert G, Broholm H, Scheie D, Cahill DP, Brastianos PK, Skjøth-Rasmussen J, Fugleholm K, Ziebell M, Munch TN, Kristensen BW, Mathiesen T.
Mirian C, et al. Among authors: juratli ta.
Neuropathol Appl Neurobiol. 2022 Apr;48(3):e12773. doi: 10.1111/nan.12773. Epub 2021 Dec 1.
Neuropathol Appl Neurobiol. 2022.
PMID: 34799864